CNCR vs. INDF
Compare and contrast key facts about Loncar Cancer Immunotherapy ETF (CNCR) and Nifty India Financials ETF (INDF).
CNCR and INDF are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CNCR is a passively managed fund by Exchange Traded Concepts that tracks the performance of the Loncar Cancer Immunotherapy Index. It was launched on Oct 13, 2015. INDF is a passively managed fund by Exchange Traded Concepts that tracks the performance of the Nifty Financial Services 25/50 Index. It was launched on Oct 20, 2020. Both CNCR and INDF are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
CNCR vs. INDF - Performance Comparison
Loading graphics...
CNCR vs. INDF - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
CNCR Loncar Cancer Immunotherapy ETF | 0.00% |
INDF Nifty India Financials ETF | 0.00% |
Returns By Period
CNCR
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
INDF
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
CNCR vs. INDF - Expense Ratio Comparison
CNCR has a 0.79% expense ratio, which is higher than INDF's 0.75% expense ratio.
Return for Risk
CNCR vs. INDF - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Nifty India Financials ETF (INDF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading graphics...
Dividends
CNCR vs. INDF - Dividend Comparison
CNCR has not paid dividends to shareholders, while INDF's dividend yield for the trailing twelve months is around 21.29%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CNCR Loncar Cancer Immunotherapy ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
INDF Nifty India Financials ETF | 21.29% | 21.29% | 6.15% | 8.84% | 3.12% | 1.58% |
Drawdowns
CNCR vs. INDF - Drawdown Comparison
Loading graphics...
Drawdown Indicators
| CNCR | INDF | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | — | — |
Average DrawdownAverage peak-to-trough decline | 0.00% | — | — |
Volatility
CNCR vs. INDF - Volatility Comparison
Loading graphics...
Volatility by Period
| CNCR | INDF | Difference | |
|---|---|---|---|
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | — | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | — | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | — | — |